~~<i id='95AA1BF15B'><strike id='95AA1BF15B'><tt id='95AA1BF15B'><pre id='95AA1BF15B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：comprehensive 2025-09-30 16:25:16 - browse：56

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Asbestos, a deadly carcinogen, banned by EPA

explore

knowledge

leisure time

explore

focus

AfterJoannaGaines,co-hostofHGTV's"FixerUpper,"shownherewithherhusband,Chip,postedanultrasoundofherba

WSS

South Korea throws huge K

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Maui's cultural, historic landmarks damaged in the devastating wildfires

American woman, child freed after being kidnapped in Haiti last month

In same hospitals, Black patients receive fewer opioids than white patients

Argenx readies a blockbuster opportunity with drug for autoimmune disease

hotspot

explore

explore

The cancer drug shortage isn’t new — and neither are the solutions

Drastic changes should bring profitability, startup health insurers say

Peter Hotez and the public health issue of online harassment

South Korea throws huge K

Psychedelics group wrestles with new pharma identity

In same hospitals, Black patients receive fewer opioids than white patients

Cancer drug shortages should be causing more outrage

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Medical records are filled with copy

American woman, child freed after being kidnapped in Haiti last month

explore

Asbestos, a deadly carcinogen, banned by EPA

Methadone treatment changes are coming. Do they go far enough?

Asbestos, a deadly carcinogen, banned by EPA

App could help diagnose ear infections more accurately — and at home

What to know about Virgin Galactic's 1st mission taking paying customers to space

Leading voice in opioid treatment defends methadone clinic system

knowledge

leisure time

explore

focus